Cubist Systematic Strategies’s Avadel Pharmaceuticals AVDL Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$2.42M Buy
273,736
+123,285
+82% +$1.09M 0.01% 685
2025
Q1
$1.18M Buy
+150,451
New +$1.18M 0.01% 834
2024
Q2
Sell
-168,528
Closed -$2.85M 1498
2024
Q1
$2.85M Buy
168,528
+159,281
+1,723% +$2.69M 0.02% 732
2023
Q4
$131K Sell
9,247
-9,338
-50% -$132K ﹤0.01% 1735
2023
Q3
$191K Sell
18,585
-86,029
-82% -$886K ﹤0.01% 1532
2023
Q2
$1.72M Buy
104,614
+55,289
+112% +$911K 0.01% 965
2023
Q1
$452K Sell
49,325
-107,885
-69% -$988K ﹤0.01% 1849
2022
Q4
$1.13M Buy
157,210
+105,401
+203% +$755K 0.01% 1669
2022
Q3
$260K Buy
+51,809
New +$260K ﹤0.01% 2850
2022
Q1
Sell
-41,370
Closed -$334K 3527
2021
Q4
$334K Buy
41,370
+23,397
+130% +$189K ﹤0.01% 2728
2021
Q3
$176K Buy
+17,973
New +$176K ﹤0.01% 2615
2020
Q4
Sell
-68,820
Closed -$347K 2553
2020
Q3
$347K Buy
+68,820
New +$347K 0.01% 1933
2020
Q2
Sell
-15,326
Closed -$122K 2390
2020
Q1
$122K Buy
+15,326
New +$122K ﹤0.01% 1859
2018
Q3
Sell
-10,820
Closed -$66K 1866
2018
Q2
$66K Buy
+10,820
New +$66K ﹤0.01% 1607
2018
Q1
Sell
-10,982
Closed -$90K 1830
2017
Q4
$90K Sell
10,982
-6,549
-37% -$53.7K ﹤0.01% 1697
2017
Q3
$184K Buy
+17,531
New +$184K 0.01% 1481
2016
Q2
Sell
-3,115
Closed -$34K 1715
2016
Q1
$34K Buy
3,115
+3,015
+3,015% +$32.9K ﹤0.01% 1498
2015
Q4
$1K Sell
100
-26,988
-100% -$270K ﹤0.01% 1727
2015
Q3
$442K Buy
+27,088
New +$442K 0.02% 1031
2015
Q2
Sell
-15,350
Closed -$276K 1819
2015
Q1
$276K Buy
+15,350
New +$276K 0.01% 1309